Bioventus to Report Fourth Quarter of Fiscal Year 2024 Financial Results on March 11, 2025
Bioventus (Nasdaq: BVS), a global leader in innovations for active healing, has scheduled its fourth quarter fiscal year 2024 financial results announcement for March 11, 2025, before market opening.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Bioventus (Nasdaq: BVS), a global leader in innovations for active healing, has scheduled its fourth quarter fiscal year 2024 financial results announcement for March 11, 2025, before market opening. The company will host a conference call at 8:30 a.m. Eastern Time on the same day, featuring management discussion of results and business updates.
Investors can participate by dialing 1-833-636-0497 and referring to the Bioventus Conference Call. A live webcast and accompanying materials will be available on the company's investor relations website, with replay access until March 10, 2026.
Details
News Market Reaction – BVS
The recorded move for BVS in the trading session of this news was +4.21%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
DURHAM, N.C., Feb. 28, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report financial results for the fourth quarter of fiscal year 2024 before the market opens on Tuesday, March 11, 2025. The Company’s management will host a conference call at 8:30 a.m. Eastern Time that same day to discuss the results and provide a business update.
To participate in the conference call, dial 1-833-636-0497 and refer to the Bioventus Inc. Conference Call.
A live webcast of the call and accompanying materials will also be provided on the “Investor Relations” section of the Company's website at https://ir.bioventus.com/. The webcast will be archived at the same site and available for replay until March 10, 2026.
About Bioventus
Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations for Active Healing from Bioventus include offerings for Pain Treatments, Restorative Therapies and Surgical Solutions. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide. For more information, visit www.bioventus.com and follow the Company on LinkedIn and Twitter. Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC.
Investor and Media Inquiries:
Dave Crawford
919-474-6787
Dave.Crawford@bioventus.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.